These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 33400277)

  • 1. Reply to: Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Cereda E; Fasano A; Pezzoli G
    Mov Disord; 2020 Sep; 35(9):1498. PubMed ID: 33400277
    [No Abstract]   [Full Text] [Related]  

  • 2. Standardized 25-Hydroxyvitamin D Measurements in Parkinson's Disease Patients With COVID-19.
    Speeckaert MM; Speeckaert R; Delanghe JR
    Mov Disord; 2020 Sep; 35(9):1497. PubMed ID: 33400280
    [No Abstract]   [Full Text] [Related]  

  • 3. An educational case series of Parkinson's disease during the COVID-19 pandemic.
    Lo Monaco MR; Colacicco G; Marotta J; Bentivoglio AR;
    Rev Neurol (Paris); 2021; 177(1-2):134-136. PubMed ID: 32951860
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 in Parkinson's disease: Report on prevalence and outcome.
    Artusi CA; Romagnolo A; Imbalzano G; Marchet A; Zibetti M; Rizzone MG; Lopiano L
    Parkinsonism Relat Disord; 2020 Nov; 80():7-9. PubMed ID: 32920322
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to: "Parkinson's Disease and COVID-19: Do We Need to Be More Patient?".
    Outeiro TF; Krisko A
    Mov Disord; 2021 Feb; 36(2):278-279. PubMed ID: 33599004
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson's disease following COVID-19: causal link or chance occurrence?
    Li WS; Chan LL; Chao YX; Tan EK
    J Transl Med; 2020 Dec; 18(1):493. PubMed ID: 33375935
    [No Abstract]   [Full Text] [Related]  

  • 7. What can Parkinson's disease teach us about COVID-19?
    Tipton PW; Wszolek ZK
    Neurol Neurochir Pol; 2020; 54(2):204-206. PubMed ID: 32323862
    [No Abstract]   [Full Text] [Related]  

  • 8. In reply to: Helmich and Bloem (2020) "The Impact of the COVID-19 Pandemic on Parkinson's Disease: Hidden Sorrows and Emerging Opportunities".
    Edwards E; Carroll C
    J Parkinsons Dis; 2020; 10(3):1267-1268. PubMed ID: 32597820
    [No Abstract]   [Full Text] [Related]  

  • 9. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels.
    Kaufman HW; Niles JK; Kroll MH; Bi C; Holick MF
    PLoS One; 2020; 15(9):e0239252. PubMed ID: 32941512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In response to: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity.
    Brown M
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):631. PubMed ID: 32671847
    [No Abstract]   [Full Text] [Related]  

  • 11. 25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2.
    D'Avolio A; Avataneo V; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M
    Nutrients; 2020 May; 12(5):. PubMed ID: 32397511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Original publication: Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity.
    Panagiotou G; Tee SA; Ihsan Y; Athar W; Marchitelli G; Kelly D; Boot CS; Stock N; Macfarlane J; Martineau AR; Burns GP; Quinton R
    Clin Endocrinol (Oxf); 2020 Nov; 93(5):629-630. PubMed ID: 32780518
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to: "Can the 2019 Novel Coronavirus Cause Parkinson's Disease?".
    Achbani A; Sine H; Naciri A; Baba MA; Kharbach A; Bouchriti Y; Nejmeddine M
    Mov Disord; 2020 Oct; 35(10):1726. PubMed ID: 33068480
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum 25-hydroxyvitamin D levels and psychological distress symptoms in patients with affective disorders during the COVID-19 pandemic.
    Di Nicola M; Dattoli L; Moccia L; Pepe M; Janiri D; Fiorillo A; Janiri L; Sani G
    Psychoneuroendocrinology; 2020 Dec; 122():104869. PubMed ID: 32956989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Vitamin D Deficiency on COVID-19-A Prospective Analysis from the CovILD Registry.
    Pizzini A; Aichner M; Sahanic S; Böhm A; Egger A; Hoermann G; Kurz K; Widmann G; Bellmann-Weiler R; Weiss G; Tancevski I; Sonnweber T; Löffler-Ragg J
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32932831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid worsening in Parkinson's disease may hide COVID-19 infection.
    Hainque E; Grabli D
    Parkinsonism Relat Disord; 2020 Jun; 75():126-127. PubMed ID: 32414669
    [No Abstract]   [Full Text] [Related]  

  • 17. Impact of home confinement during COVID-19 pandemic on Parkinson's disease.
    Kumar N; Gupta R; Kumar H; Mehta S; Rajan R; Kumar D; Kandadai RM; Desai S; Wadia P; Basu P; Mondal B; Sanchita ; Rawat A; Meka SS; Mishal B; Prashanth LK; Srivastava AK; Goyal V
    Parkinsonism Relat Disord; 2020 Nov; 80():32-34. PubMed ID: 32937224
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risk and course of COVID-19 in patients with Parkinson's disease].
    Zalyalova ZA; Khasanova DM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(9):152-156. PubMed ID: 34693704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is COVID-19 a Perfect Storm for Parkinson's Disease?
    Brundin P; Nath A; Beckham JD
    Trends Neurosci; 2020 Dec; 43(12):931-933. PubMed ID: 33158605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
    Suzuki M; Yoshioka M; Hashimoto M; Murakami M; Kawasaki K; Noya M; Takahashi D; Urashima M
    Mov Disord; 2012 Feb; 27(2):264-71. PubMed ID: 22213340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.